Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Peck

Showing results (421-430 of 490) with videos related to

Pageof 49
Sort By:
Journal of Pharmaceutical Sciences|August 23, 2012
Impact of the pharmaceutical sciences on health care: a reflection over the past 50 yearsMalcolm Rowland, Christian R Noe, Dennis A Smith, et al.
Science (New York, N.Y.)|October 12, 2013
Evidence that the fosfomycin-producing epoxidase, HppE, is a non-heme-iron peroxidaseChen Wang, Wei-chen Chang, Yisong Guo, et al.
Clinical & Translational Immunology|February 22, 2020
Risk stratification biomarkers for <i>Staphylococcus aureus</i> bacteraemiaYi Cao, Alessander O Guimaraes, Melicent C Peck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2016
Chronic Neuropathic Pain: It's about the RhythmZeynab Alshelh, Flavia Di Pietro, Andrew M Youssef, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Transfusion|July 1, 1977
The in vivo survival of red blood cells stored in modified CPD with adenine: report of a multi-institutional cooperative effortT F Zuck, T A Bensinger, C C Peck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugsGary J Kelloff, Richard L Schilsky, David S Alberts, et al.
Journal of the American Chemical Society|January 17, 2017
O-H Activation by an Unexpected Ferryl Intermediate during Catalysis by 2-Hydroxyethylphosphonate DioxygenaseSpencer C Peck, Chen Wang, Laura M K Dassama, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pageof 49

Showing results (421-430 of 490) with videos related to

Sort By:
Pageof 49
Journal of Pharmaceutical Sciences|August 23, 2012
Impact of the pharmaceutical sciences on health care: a reflection over the past 50 yearsMalcolm Rowland, Christian R Noe, Dennis A Smith, et al.
Science (New York, N.Y.)|October 12, 2013
Evidence that the fosfomycin-producing epoxidase, HppE, is a non-heme-iron peroxidaseChen Wang, Wei-chen Chang, Yisong Guo, et al.
Clinical & Translational Immunology|February 22, 2020
Risk stratification biomarkers for <i>Staphylococcus aureus</i> bacteraemiaYi Cao, Alessander O Guimaraes, Melicent C Peck, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 22, 2016
Chronic Neuropathic Pain: It's about the RhythmZeynab Alshelh, Flavia Di Pietro, Andrew M Youssef, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Transfusion|July 1, 1977
The in vivo survival of red blood cells stored in modified CPD with adenine: report of a multi-institutional cooperative effortT F Zuck, T A Bensinger, C C Peck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugsGary J Kelloff, Richard L Schilsky, David S Alberts, et al.
Journal of the American Chemical Society|January 17, 2017
O-H Activation by an Unexpected Ferryl Intermediate during Catalysis by 2-Hydroxyethylphosphonate DioxygenaseSpencer C Peck, Chen Wang, Laura M K Dassama, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pageof 49